Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03221868
Other study ID # diabetes7005
Secondary ID
Status Completed
Phase N/A
First received December 27, 2016
Last updated August 25, 2017
Start date August 2016
Est. completion date July 2017

Study information

Verified date August 2017
Source Federal University of Pelotas
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study aims at evaluating the effects of an intervention among diabetic women (40 years or older) who belong to the Basic Health Units System (Brazilian public health system). The novelty of this project is that the intervention is low cost and demands very little from the health system in terms of structure, facilities and personnel.


Description:

The objective of this project is to evaluate the effect of a physical exercise program on the biochemical profile of type 2 diabetic women users of Basic Health Units (BHU) in the urban area of the city of Pelotas (Brazil). This is a randomized clinical trial, where two BHU's of the 14 eligible for the study will be drawn for inclusion in the study. Only those units with more than 100 registered diabetic patients are eligible, they also are not linked to educational institutions and do not present Physical activity projects. Four Basic Health Units (BHU) of the municipality of Pelotas (Brazil) were randomized, two for the intervention group and two for the control group. The intervention group will perform circuit-like physical exercises three times a week and the control will receive counseling to practice physical activity and meetings every 15 days with the womens to carry out walks. The program lasted 12 weeks, with three weekly sessions and presented four distinct sequences containing 10 exercises each, which were performed and circuit form and modified every three weeks. In the first week of the intervention, the women performed a passage in the circuit and with each new week a passage was increased, until the number of three passes was reached (number of passages kept fixed until the end of the intervention). Each exercise initially had a duration of 30 seconds, with a duration of 10 seconds added every three weeks up to a maximum of 60 seconds; The interval of 30 seconds between exercises was kept fixed throughout the intervention. The intensity was controlled by the subjective perception of effort. Mainly blood chemistry will be measured and evaluated.Possible confounding factors to be controlled: age, skin color, schooling, family income, weight, Body Mass Index (BMI), alcohol consumption, smoking, waist circumference, time to diagnose the disease, use of Medicines for diabetes and eating habits. The information will be collected at the baseline, at the eighth week and at the end of the study. Descriptive analyzes of the data will be performed initially, the associations will be tested by correlation, t-test and ANOVA for repeated measures. For comparisons of categorical variables, Chi-square tests will be used for heterogeneity or linear trend. The multivariate analysis will be run through logistic regression. The analyzes will be performed by intention to treat and by adherence, and the level of significance accepted for the study will be 5%. This study will seek to fill gaps in the knowledge about intervention studies in BHU's in order to identify whether physical exercise interventions with proper planning and orientation can promote improvements in the severity of the disease in diabetic women.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date July 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender Female
Age group 40 Years to 85 Years
Eligibility Inclusion Criteria:

- females;

- type 2 diabetic;

- diagnosed for more than one year;

- BMI =25 kg / m²;

- age between 40 and 60 years.

Exclusion Criteria:

- BMI = 40 kg / m²;

- history of stroke;

- neuropathy or severe retinopathy;

- any serious medical condition that prevents the participant to exercise safely;

- history of severe physical disability

- history of acute myocardial infarction in the last six months.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise group
An exercise-based program following a 12-week periodization using mostly circuit-like activities.
Control group
Counseling to practice physical activity and meetings every 15 days with women to conduct group walks. Booklet with walking schedule and for registering sessions.

Locations

Country Name City State
Brazil Physical Education School of the Federal University of Pelotas Pelotas Rio Grande do Sul

Sponsors (1)

Lead Sponsor Collaborator
Federal University of Pelotas

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in HbA1c - Glycated hemoglobin - % Measured at baseline, and the end of intervention, 12th week
Secondary Change in Glucose Fasting glucose - mg/dl Measured at baseline, and the end of intervention, 12th week
Secondary Change in Insulin Fasting insulin - µI/ml Measured at baseline, and the end of intervention, 12th week
Secondary Change in BP - Blood pressure - mm/hg measured with an automated equipment; Measured at baseline, and the end of intervention, 12th week
Secondary Change in Insulin resistance Insulin resistance - Insulin (µI/L) X Fasting Glycemia (mg/dl)/405 Measured at baseline, and the end of intervention, 12th week
Secondary Change in Triglycerides Triglycerides - mg/dl Measured at baseline, and the end of intervention, 12th week
Secondary Change in Cholesterol Total cholesterol and subfractions - mg/dl Measured at baseline, and the end of intervention, 12th week
Secondary Change in CRP C-reactive protein - mg/l Measured at baseline, and the end of intervention, 12th week
Secondary Change in CRF - Cardiorespiratory fitness - calculated based on the distance covered during the 6-minute walking test; Measured at baseline, and the end of intervention, 12th week
Secondary Change in LLS - Lower limb strength - number of repetitions performed during the 30-Second Chair Stand Test; Measured at baseline, and the end of intervention, 12th week
Secondary Change in QoL - Quality of life (SF-36) - sum of the scores of the scale. Measured at baseline, and the end of intervention, 12th week
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A